A detailed history of Great Diamond Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Great Diamond Partners, LLC holds 7,394 shares of LLY stock, worth $5.54 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
7,394
Previous 8,487 12.88%
Holding current value
$5.54 Million
Previous $7.68 Million 14.75%
% of portfolio
1.69%
Previous 1.83%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $843,949 - $1.05 Million
-1,093 Reduced 12.88%
7,394 $6.55 Million
Q2 2024

Jul 29, 2024

SELL
$724.87 - $909.04 $47,116 - $59,087
-65 Reduced 0.76%
8,487 $7.68 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $850,991 - $1.14 Million
-1,437 Reduced 14.39%
8,552 $6.65 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $151,779 - $178,928
-289 Reduced 2.81%
9,989 $5.82 Million
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $19,996 - $27,567
46 Added 0.45%
10,278 $5.52 Million
Q2 2023

Jul 17, 2023

SELL
$350.74 - $468.98 $4,910 - $6,565
-14 Reduced 0.14%
10,232 $4.8 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $283,605 - $333,080
913 Added 9.78%
10,246 $3.52 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $18,328 - $21,356
57 Added 0.61%
9,333 $3.41 Million
Q3 2022

Oct 24, 2022

SELL
$296.48 - $337.87 $55,441 - $63,181
-187 Reduced 1.98%
9,276 $3 Million
Q2 2022

Jul 26, 2022

BUY
$278.73 - $327.27 $1.67 Million - $1.96 Million
5,996 Added 172.94%
9,463 $3.07 Million
Q1 2022

May 05, 2022

SELL
$234.69 - $291.66 $24,173 - $30,040
-103 Reduced 2.89%
3,467 $992,000
Q4 2021

Jan 26, 2022

BUY
$224.85 - $279.04 $23,834 - $29,578
106 Added 3.06%
3,570 $986,000
Q3 2021

Oct 21, 2021

BUY
$221.6 - $272.71 $5,983 - $7,363
27 Added 0.79%
3,464 $800,000
Q2 2021

Jul 26, 2021

BUY
$180.55 - $233.54 $16,971 - $21,952
94 Added 2.81%
3,437 $788,000
Q1 2021

May 04, 2021

SELL
$164.32 - $212.72 $107,958 - $139,757
-657 Reduced 16.43%
3,343 $624,000
Q4 2020

Jan 26, 2021

SELL
$130.46 - $172.63 $43,704 - $57,831
-335 Reduced 7.73%
4,000 $675,000
Q3 2020

Oct 19, 2020

BUY
$146.22 - $169.13 $5,995 - $6,934
41 Added 0.95%
4,335 $641,000
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $459,114 - $568,654
4,294 New
4,294 $564,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.